Skip to main content

Animations

MJFF Publications

1631 - 1640 of 8471 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Isolated Jaw and Tongue Tremor in a Definite Case of Progressive Supranuclear Palsy
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13640
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: LRRK2-targeted Parkinson disease drug advances into phase III
    Journal Name: Nature Reviews Drug Discovery
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/d41573-022-00212-0
    Best OA location URL:
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networks
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-25454-1
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The genetic regulation of protein expression in cerebrospinal fluid
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202216359
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete Recovery
    Journal Name: Annals of Otology, Rhinology & Laryngology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/00034894221138485
    Citation Count: 2
  • Summary Details
    OPEN
    Title: It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29279
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose Adjustment
    Journal Name: European Medical Journal
    Publisher: European Medical Group
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.33590/emj/10022165
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Brain vitamin D forms, cognitive decline, and neuropathology in community‐dwelling older adults
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12836
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Spectrum of Pediatric to Early Adulthood POLR3A‐Associated Movement Disorders
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13635
    Best OA location URL:
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.